Bone mineral density and inflammatory bowel disease severity

Area of Science:

• Gastroenterology
• Endocrinology
• Rheumatology

Background:

• Inflammatory bowel disease (IBD), encompassing Crohn's disease (CD) and ulcerative colitis (UC), is frequently linked to diminished bone mineral density (BMD).
• Understanding the specific factors contributing to low BMD in IBD patients is crucial for targeted interventions.

Purpose of the Study:

• To evaluate the association between disease severity and BMD in patients with IBD.
• To investigate the relationship between BMD and disease characteristics, including the Montreal classification, disease activity, and drug therapy.

Main Methods:

• A cross-sectional prevalence study was conducted with 128 IBD patients (68 UC, 60 CD) and 67 healthy controls.
• Bone mineral density (BMD) was measured in all participants. Disease characteristics, medication use, and hospitalization history were recorded for IBD patients.
• Multiple correspondence analysis was used to analyze categorical variables.

Main Results:

• Both UC and CD patients exhibited a significantly higher likelihood of osteopenia compared to controls.
• In CD, low BMD was associated with male gender, perianal disease, penetrating behavior, and diagnosis after age 40. Azathioprine and infliximab use also appeared linked to osteopenia.
• In UC, low BMD correlated with male gender, left-sided colitis, corticosteroid use, and hospitalization. Disease activity was not directly associated with osteopenia or osteoporosis in either group.

Conclusions:

• Disease severity and specific clinical factors, rather than current disease activity, appear to be associated with low bone mineral density in IBD patients.
• These findings highlight the importance of considering patient-specific factors and disease characteristics in managing bone health in individuals with IBD.